Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JOE, MARY

NPI: 1063402659 · LAWRENCE, MA 01843 · Emergency Medicine Physician · NPI assigned 10/25/2005

$502K
Total Medicaid Paid
4,704
Total Claims
4,586
Beneficiaries
12
Codes Billed
2018-01
First Month
2023-02
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 123 $8K
2019 157 $23K
2020 971 $122K
2021 1,974 $171K
2022 1,212 $143K
2023 267 $36K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
S9083 Global fee urgent care centers 3,182 3,102 $409K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 361 348 $51K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 129 128 $15K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 163 162 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 37 37 $6K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 83 81 $4K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 169 166 $4K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 28 28 $2K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 44 44 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12 12 $1K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 244 235 $300.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 252 243 $10.50